UNSPSC 85541912: Revision of autologous tissue substitute in thoracic duct, percutaneous endoscopic approach

This classification denotes the group of activities that yields a surgical intervention or procedure to revision of autologous tissue substitute in thoracic duct, percutaneous endoscopic approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 07WK47Z

UNSPSC 85541912 Revision of autologous tissue substitute in thoracic duct, percutaneous endoscopic approach is a Commodity code that shows little relevant recent activity under state and local procurement. The six recent opportunities tagged to this code span independent medical evaluation services, surgical benefit carve-outs, occupational medical surveillance, youth detention healthcare, pharmacy benefit management, and temporary health professional staffing—none of which align with the code's nominal scope of thoracic-duct tissue-substitute revision procedures. The mismatch suggests either tagging error by the issuing bodies or that this code is not actively used for actual state and local medical procurement.

The recent opportunities do reflect broader state and local demand for medical administration and clinical staffing. The City of Phoenix Retirement Office posted an RFP (RTMRFP26001, due October 16, 2026) for independent medical evaluation services supporting disability benefit determinations; the City of Long Beach posted an RFP (HR26753, due October 7, 2026) for surgical center-of-excellence networks under its Anthem PPO plan; the Washington State Department of Transportation posted an RFP (RFP20260825, due October 9, 2026) for occupational medical surveillance across 14 ferry terminals; and Santa Clara County Health System posted an RFQ (RFSQHHSFY270052, due October 7, 2026) for temporary ancillary clinical staffing. Activity spans Arizona, California, Florida, and Washington, but does not concentrate around the thoracic-duct procedure code. Until the source identifies opportunities that explicitly solicit thoracic-duct tissue-substitute work, this code should be treated as inactive for state and local business development purposes.